Is salvage chemotherapy for metastatic breast cancer always effective and well tolerated? A phase II randomized trial of vinorelbine versus 5-fluorouracil plus leucovorin versus combination of mitoxantrone, 5-fluorouracil plus leucovorin

By Venturino A.  

Breast Cancer Research and Treatment, Vol. 60, Iss. 3, 2000-04 ,pp. : 195-200

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study

By Morales Serafín   Lorenzo Antonio   Ramos Manuel   Ballesteros Pedro   Méndez Miguel   Almanza Concepción   Castellanos Javier   Moreno-Nogueira José   Casal Joaquín   Lizón José   Oltra Amparo   Frau Adolfo   Machengs Ignacio   Galán Antonio   Belón Joaquín   Llorca Cristina  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 75-81

Springer Publishing Company

Access to resources Recommend Favorite

Do Research Perspectives Exist for Further Anti-EGFR Targeted Therapies in Patients with Breast Cancer?

By Theohari Irini  

The Journal of OncoPathology, Vol. 1, Iss. 1, 2013-04 ,pp. : 15-19

Optimal Clinical Ltd

Access to resources Recommend Favorite

Is family history related to preventive health behaviors and medical management in breast cancer patients?

By Madlensky Lisa  

Breast Cancer Research and Treatment, Vol. 90, Iss. 1, 2005-03 ,pp. : 47-54

Springer Publishing Company

Access to resources Recommend Favorite

Are medical oncologists biased in their treatment of the large woman with breast cancer?

By Madarnas Y.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 2, 2001-03 ,pp. : 123-133

Springer Publishing Company

Access to resources Recommend Favorite